clinical trial for retatrutide Retatrutide: A Promising Option Non-Diabetic Weight Loss in Trials Retatrutide UK: 2026 Clinical Trial

News provided by Designs for Health Jun 17, 2026, 10:17 ET New probiotic and postbiotic blend targets microbiome health, metabolic balance, and healthy body composition through clinically studied ingredients* PALM COAST, Fla., June 17, 2026 /PRNewswire/ -- Designs for Health, the practitioner-recommended and preferred brand for high-quality, research-backed supplements, today announced the launch of Akkermansia Pro GLP-1 Probiotic, a groundbreaking once-daily probiotic and postbiotic formula that combines live Akkermansia muciniphila with the clinically studied BPL1 postbiotic to support the gutmetabolic connection, the body's natural GLP-1 production, and healthy weight management.* As research continues to explore the connection between the gut microbiome and metabolic health, emerging science suggests that specific keystone bacterial strains, those that are foundational to the gut microbiome, may play a vital role in supporting appetite regulation, blood sugar metabolism, gut barrier integrity, and overall metabolic resilience

A higher-dose Wegovy In a press release, Novo Nordisk highlighted the potential for their higher-dose Wegovy to lead to even greater weight loss benefits for patients

Blood sugar readings stop improving

A ativao desses receptores promove a vasodilatao e auxilia na reduo da presso arterial sistlica

Q: How do GLP-1s interact with nutrition, the microbiome and individual metabolism

Required video consultation with an obesity medicine provider, plus a consultation with a registered dietitian before the prescription is written